The Feasibility of Pertussis Immunization in a Canadian Emergency Department

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

644 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-07-10

Study Completion Date

2017-12-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine to patients presenting to the emergency department. Rates of vaccination as well as effects on department efficiency will be measured.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Point-of-care Testing of Respiratory Pathogens at Pediatric Emergency Room

NCT03932942

Respiratory Tract Infections

COMPLETED NA

Emergency Department Healthcare Education Assessment and Response for Teen Relationships: A Pilot Feasibility Study

NCT05194202

Adolescent Behavior Emergency Department Abuse Physical +5 more

COMPLETED NA

Painful Procedures in the Emergency Department: A Distraction Intervention

NCT00338364

Pediatric Pain and Anxiety

COMPLETED PHASE2

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

NCT06156215

COVID-19

COMPLETED NA

Best Strategies for Implementation of Clinical Pathways in Emergency Department Settings

NCT01815710

Asthma Diarrhea & Vomiting

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a prospective randomized, controlled trial of two strategies to provide patients with the pertussis vaccine. Eligible adult patients with be offered pertussis vaccination in the Emergency Department vs. a referral to Public Health for pertussis vaccination. The effect of both strategies on triage time as well as measure of emergency department efficiency including length of stay, time to physician and left without being seen rates will be compared. At a four-month follow up, rates of pertussis vaccination will be measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pertussis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emergency Department vaccination group

Pertussis (Tdap) vaccine offered/administered in the Emergency Department

Group Type EXPERIMENTAL

Tdap

Intervention Type BEHAVIORAL

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine

Public Health referral group

Public Health referral for Pertussis (Tdap) vaccine administration offered

Group Type EXPERIMENTAL

Tdap

Intervention Type BEHAVIORAL

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Tdap

Randomized controlled trial of 2 strategies to provide adults with the Tdap vaccine

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Boostrix

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults age 18 and above
* Have not received Tdap vaccine as an adult (age 18 and above) or have not received Tdap vaccine within 10 years, or unsure of vaccination status

Exclusion Criteria

* Acute significant illness (Canadian Triage and Acuity Scale = 1)
* Deemed "in too much distress" by triage nurse
* Acute Febrile illness
* Allergy to vaccine or vaccine components
* Pts presenting for wound care (are normally given the vaccine as part of wound care)
* Pregnancy \< 26 weeks

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes